188 related articles for article (PubMed ID: 8270489)
1. Novel cytocidal compounds, oxopropalines from Streptomyces sp. G324 producing lavendamycin. II. Physico-chemical properties and structure elucidations.
Abe N; Enoki N; Nakakita Y; Uchida H; Nakamura T; Munekata M
J Antibiot (Tokyo); 1993 Nov; 46(11):1678-86. PubMed ID: 8270489
[TBL] [Abstract][Full Text] [Related]
2. Novel cytocidal compounds, oxopropalines from Streptomyces sp. G324 producing lavendamycin. I. Taxonomy of the producing organism, fermentation, isolation and biological activities.
Abe N; Nakakita Y; Nakamura T; Enoki N; Uchida H; Takeo S; Munekata M
J Antibiot (Tokyo); 1993 Nov; 46(11):1672-7. PubMed ID: 8270488
[TBL] [Abstract][Full Text] [Related]
3. Novel antitumor antibiotics, saptomycins. II. Isolation, physico-chemical properties and structure elucidation.
Abe N; Enoki N; Nakakita Y; Uchida H; Nakamura T; Munekata M
J Antibiot (Tokyo); 1993 Oct; 46(10):1536-49. PubMed ID: 8244881
[TBL] [Abstract][Full Text] [Related]
4. 10'-Desmethoxystreptonigrin, a novel analog of streptonigrin.
Liu WC; Barbacid M; Bulgar M; Clark JM; Crosswell AR; Dean L; Doyle TW; Fernandes PB; Huang S; Manne V
J Antibiot (Tokyo); 1992 Apr; 45(4):454-7. PubMed ID: 1592677
[TBL] [Abstract][Full Text] [Related]
5. A new pyrrolosesquiterpene isolated from cultures of Streptomyces sp.
Liu DZ; Liang BW
J Antibiot (Tokyo); 2014 May; 67(5):415-7. PubMed ID: 24549152
[TBL] [Abstract][Full Text] [Related]
6. Kazusamycin B, a novel antitumor antibiotic.
Funaishi K; Kawamura K; Sugiura Y; Nakahori N; Yoshida E; Okanishi M; Umezawa I; Funayama S; Komiyama K
J Antibiot (Tokyo); 1987 Jun; 40(6):778-85. PubMed ID: 3610834
[TBL] [Abstract][Full Text] [Related]
7. SW-163C and E, novel antitumor depsipeptides produced by Streptomyces sp. II. Structure elucidation.
Takahashi K; Koshino H; Esumi Y; Tsuda E; Kurosawa K
J Antibiot (Tokyo); 2001 Aug; 54(8):622-7. PubMed ID: 11592498
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis of novel 6-substituted lavendamycin antitumor agents.
Seradj H; Cai W; Erasga NO; Chenault DV; Knuckles KA; Ragains JR; Behforouz M
Org Lett; 2004 Feb; 6(4):473-6. PubMed ID: 14961601
[TBL] [Abstract][Full Text] [Related]
9. The synergistic antibacterial activity of 1-acetyl-beta-carboline and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
Shin HJ; Lee HS; Lee DS
J Microbiol Biotechnol; 2010 Mar; 20(3):501-5. PubMed ID: 20372018
[TBL] [Abstract][Full Text] [Related]
10. Monacycliones G-K and
Chang Y; Xing L; Sun C; Liang S; Liu T; Zhang X; Zhu T; Pfeifer BA; Che Q; Zhang G; Li D
J Nat Prod; 2020 Sep; 83(9):2749-2755. PubMed ID: 32840364
[TBL] [Abstract][Full Text] [Related]
11. [Induction of antibiotic formation by inactive cultures of actinomycetes. A mutant strain of Streptomyces helvaticus, a new producer of bruneomycin].
Malkina ND; Dudnik IuV; Lysenkova LN; Terekhova LP; Katrukha GS
Antibiot Khimioter; 1995 Jun; 40(6):3-6. PubMed ID: 8593091
[TBL] [Abstract][Full Text] [Related]
12. Dimeric Tetrahydroanthracene Regioisomers and Their Monomeric Precursor Produced by
Wang J; Wang H; Sun C; Li F; Wu Y; Zhang G; Gu Q; Zhu T; Li D; Che Q
J Nat Prod; 2020 Sep; 83(9):2797-2802. PubMed ID: 32880456
[TBL] [Abstract][Full Text] [Related]
13. Studies on the isotetracenone antibiotics. IV. Hatomarubigins A, B, C and D, new isotetracenone antibiotics effective against multidrug-resistant tumor cells.
Hayakawa Y; Ha SC; Kim YJ; Furihata K; Seto H
J Antibiot (Tokyo); 1991 Nov; 44(11):1179-86. PubMed ID: 1761414
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial and antitumor macrolides from Streptomyces sp. Is9131.
Zhao PJ; Fan LM; Li GH; Zhu N; Shen YM
Arch Pharm Res; 2005 Nov; 28(11):1228-32. PubMed ID: 16350846
[TBL] [Abstract][Full Text] [Related]
15. R1128 substances, novel non-steroidal estrogen-receptor antagonists produced by a Streptomyces. II. Physico-chemical properties and structure determination.
Hori Y; Takase S; Shigematsu N; Goto T; Okuhara M; Kohsaka M
J Antibiot (Tokyo); 1993 Jul; 46(7):1063-8. PubMed ID: 8360100
[TBL] [Abstract][Full Text] [Related]
16. The kapurimycins, new antitumor antibiotics produced by Streptomyces. Physico-chemical properties and structure determination.
Yoshida M; Hara M; Saitoh Y; Sano H
J Antibiot (Tokyo); 1990 Dec; 43(12):1519-23. PubMed ID: 2276971
[TBL] [Abstract][Full Text] [Related]
17. Heteroaryl cross-coupling as an entry toward the synthesis of lavendamycin analogues: a model study.
Verniest G; Wang X; De Kimpe N; Padwa A
J Org Chem; 2010 Jan; 75(2):424-33. PubMed ID: 20017470
[TBL] [Abstract][Full Text] [Related]
18. Total syntheses of novel cytocidal beta-carboline alkaloids, oxopropalines D and G.
Choshi T; Kuwada T; Fukui M; Matsuya Y; Sugino E; Hibino S
Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):108-13. PubMed ID: 10705485
[TBL] [Abstract][Full Text] [Related]
19. Chrymutasins: novel-aglycone antitumor antibiotics from a mutant of Streptomyces chartreusis. II. Characterization and structural elucidation.
Uchida H; Nakakita Y; Enoki N; Abe N; Nakamura T; Munekata M
J Antibiot (Tokyo); 1994 Jun; 47(6):655-67. PubMed ID: 8040070
[TBL] [Abstract][Full Text] [Related]
20. A novel ansamycin, naphthomycin K from Streptomyces sp.
Lu C; Shen Y
J Antibiot (Tokyo); 2007 Oct; 60(10):649-53. PubMed ID: 17965482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
